Lates News

Citius Oncology (CTOR.US): The revenue in the Q4 2025 financial report was 0 US dollars, the same as the previous value; the earnings per share were -0.06 US dollars, compared to -0.14 US dollars, and the expected value was -0.06 US dollars.